MedTrace Logo

The EASYTRAK EPI Clinical Investigation

NCT00158925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-05-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the safety and effectiveness of the EASYTRAK EPI lead.

Conditions

  • Bradycardia
  • Congestive Heart Failure

Interventions

DEVICE

EASYTRAK EPI lead

EASYTRAK EPI lead

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Daniel Beckman, MD · The Methodist Hospital Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00158925 on ClinicalTrials.gov